PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Klymat's SaaS business model transforms vehicle fleet management for organizations and fulfills employees' transportation requirements. Through a centralized online platform offered via monthly subscriptions, Klymat empowers businesses to monitor their entire vehicle fleet and employee journeys, regardless of transportation mode. The software computes total business mobility costs and carbon emissions, providing a simpler, more visible, flexible, cost-effective, sustainable, and eco-friendly approach to corporate travel.
days to go:
Expired
investment:
Withheld
An app designed to help families manage their household bills in one place. Onedox have increased their user base over threefold to 16,000 users since June 2017 and manage more than £21m worth of customer expenditure with over 700m bills downloaded for their customers to view. The company has participated in the 'Accenture Fintech Innovation Lab' and 'NatWest Entrepreneur Fintech Accelerator' programmes, as well as being finalists in the 'British Banking Awards 2018'.
days to go:
Expired
investment:
£358,120
Thrive facilitates individuals' investment in clean energy projects to create a smarter, clean energy system. With over 6,000 shareholders, we've amassed a £110m portfolio in wind, solar, hydro, and battery assets, aiming for further expansion. Our diversified portfolio yields predictable incomes and reduces carbon emissions in the UK while decreasing reliance on fossil fuels.
Our revenue primarily comes from selling electricity generated by these clean energy ventures and associated government incentives. Additionally, we earn interest by funding new clean energy projects. Future plans involve investing in building renewable generation capacity and battery storage, along with providing funding for community-owned and commercial ventures to do the same.
days to go:
Expired
investment:
£5,396,950
Yielders is a real-estate investment platform that minimises the barriers of entering a traditionally inaccessible asset class. This award-winning platform is the UK’s first finance FinTech company which is regulated by FCA. The company had received authorization from FCA in 2017. Yielders received 2017 Islamic Economy Award and became finalist twice for the EFICA Innovative Finance award. It also received IFN's global award for the Best Islamic Crowdfunding Platform category. The company has over 2500 on-boarded investors. The company has achieved and completed more than £6m AUM. Yielders aims to deliver steady returns for a conscientious modern investor. Yielders plans to utilise the proceeds for product development, technology, talent acquisition, and building its presence around GCC, the UK and the global Islamic Market.
days to go:
Expired
investment:
£686,178
